MERGER AGREEMENT By and Among JANSSEN BIOTECH, INC., DOGFISH MERGER SUB, INC., BENEVIR BIOPHARM, INC. and SHAREHOLDER REPRESENTATIVE SERVICES LLC as Holder Representative May 1, 2018Merger Agreement • May 3rd, 2018 • Hc2 Holdings, Inc. • Fabricated structural metal products • Delaware
This MERGER AGREEMENT (this “Agreement”) dated as of May 1, 2018 is made and entered into by and among Janssen Biotech, Inc., a Pennsylvania corporation (the “Purchaser”), Dogfish Merger Sub, Inc., a Delaware corporation (“Merger Sub”), BeneVir Biopharm, Inc., a Delaware corporation (the “Company”), and Shareholder Representative Services LLC, a Colorado limited liability company, solely in its capacity as the Holder Representative hereunder.
SECOND AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENTLimited Liability Company Agreement • May 3rd, 2018 • Hc2 Holdings, Inc. • Fabricated structural metal products • Delaware
THIS SECOND AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT (as amended, supplemented, restated or otherwise modified from time to time, this “Agreement”) OF PANSEND LIFE SCIENCES, LLC (the “Company”), dated as of September 20, 2017, by and among HC2 Holdings 2, Inc., a Delaware corporation (“HC2”) and the individuals listed on Annex A hereto (together with HC2, each a “Member” and, collectively, the “Members”).
